NCT06667232Recruiting
Evaluating Modulation Effects of Burst Stimulation Patterns Using SEEG
Source: ClinicalTrials.gov · Last updated 22 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study aims to evaluate modulation effects of burst stimulation patterns via SEEG.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 27 Oct 2024
- Start date
- Jan 2025
- Primary completion date
- Dec 2025
- Lead sponsor
- Xuanwu Hospital, Beijing
- Diseases
- Epilepsy
- NCT number
- NCT06667232
What you commit to
- Study type: Interventional
- Planned participants: 20
- From Jan 2025 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of cranial trauma serious (according to the classification), previous or evolutionary other neurological pathology
- Subjects that experience surgical complications during the implant procedure will be excluded from the study
Other illness
- Psychiatric disorders
- History of psychotic disorders
Other
- Pregnant women (Contraindication to SEEG exploration)
Who the study is looking for
- Drug-resistant focal epilepsy
- Justified SEEG exploration in the context of presurgical assessment of epilepsy
- Subjects will be a part of the epilepsy-monitoring unit for long-term SEEG recordings and analysis
- Written non-opposition to study participation
Age in the registry: 14 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xuanwu Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.